Market
Median Technologies and Olea sign partnership for lung cancer device
Median Technologies partnered with Olea Medical to commercialize eyonis LCS, a lung cancer screening software, across the US and European markets. The collaboration expands distribution capabilities for the AI-enabled diagnostic tool designed to support lung nodule analysis in imaging workflows.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network